Finally, GM-CSF delivery has also been achieved clinically using allogenic breast cancer cells engineered to secrete high levels of GM-CSF, termed SV-BR-1-GM cells [134,135] (NCT00095862). This evidence concerns the gene CSF2 and breast cancer.